Fighting cancer can leave patients tired to their bones and researchers now think they might know why. Inflammation was linked to fatigue among nearly 200 women with early-stage breast cancer during and after treatment with radiation or chemotherapy, researchers reported Oct. 6 in the journal Cancer. Specifically, inflammation appeared to promote general and physical fatigue…  read on >  read on >

Inhalers provide breath-saving relief to people with asthma and COPD, but ultimately are undoing those good works by promoting climate change, a new study says. Inhalers generated more than 2 million metric tons of carbon emissions annually over the past decade, researchers reported Oct. 6 in the Journal of the American Medical Association. By researchers’…  read on >  read on >

A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure, a new study says. Sotatercept reduced patient’s risk of deterioration by 76% due to pulmonary hypertension, or high blood pressure in the heart-to-lung system, researchers reported recently in the New England Journal…  read on >  read on >

Seasonal allergies are considered an annoyance to most, and maddening to some. Few think of seasonal sniffles and sneezes as potentially fatal — but we might be overlooking the danger they pose, a new study warns. High pollen counts are linked to a significant increase in suicide risk, according to findings published in the December…  read on >  read on >

A new low-cost version of the abortion pill mifepristone just received federal approval and it’s already stirring political controversy. The U.S. Food and Drug Administration (FDA) recently granted approval to Evita Solutions for its generic version of mifepristone, a medication used to end early pregnancies up to 10 weeks.  The original version of mifepristone has…  read on >  read on >